To hear about similar clinical trials, please enter your email below
Trial Title:
Characteristics of Cardiac Tumor and the Risk Stratification of Subsequent Adverse Events (UNIQUE)
NCT ID:
NCT06100328
Condition:
Cardiac Tumor
Conditions: Official terms:
Heart Neoplasms
Conditions: Keywords:
Cardiac tumor
Disease characteristics
Prognosis
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Other
Summary:
This study aims to retrospectively and prospectively collect clinical and biological
specimen data from patients with cardiac tumors who meet the inclusion and exclusion
criteria. Various techniques, including general molecular biology analysis and
multi-omics analysis, will be used to construct a prognostic model for cardiac tumors.
Detailed description:
This study aims to construct a retrospective-prospective long-term follow-up cohort and
management system for cardiac tumors through a multi-centre collaborative network. The
duration of the study will be divided into retrospective and prospective components. The
retrospective study will collect cases of cardiac tumors from 2003-2022; the prospective
study is expected to collect cases of cardiac tumors from 2022-2030. The study is
expected to assess the disease characteristics, progression patterns, clinical features,
natural course and long-term prognosis of cardiac tumors.
Criteria for eligibility:
Study pop:
All patients must meet at least one of the following diagnostic criteria for cardiac
neoplasms: 1. Cardiac myxoma group; 2. Cardiac fibroma group; 3. Cardiac lipoma group; 4.
Cardiac hemangioma group; 5. Cardiac undifferentiated sarcoma; 6. Cardiac angiosarcoma
group; 7. Cardiac rhabdomyosarcoma group; 8. Cardiac lymphoma group; 9. Cardiac
metastasis group; 10. Other cardiac tumors group.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Patients who are regularly visited and followed up in the corresponding
cardiovascular center.
- All patients must meet at least one of the following diagnostic criteria for cardiac
neoplasms: 1. Cardiac myxoma group; 2. Cardiac fibroma group; 3. Cardiac lipoma
group; 4. Cardiac hemangioma group; 5. Cardiac undifferentiated sarcoma; 6. Cardiac
angiosarcoma group; 7. Cardiac rhabdomyosarcoma group; 8. Cardiac lymphoma group; 9.
Cardiac metastasis group; 10. Other cardiac tumors group.
Exclusion Criteria:
- Age <3 years or >80 years old.
- Pregnant and lactating women.
- The patient declined to provide informed consent to participate in the study.
- None of the above was met, but the patient was temporarily unable to sign the
informed consent form due to coma and other reasons, and no legal representative
signed it instead. Depending on the patient's condition, the patient may not be able
to regain consciousness and sign the informed consent form.
Gender:
All
Minimum age:
3 Years
Maximum age:
80 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
First Affiliated Hospital of Xi'an Jiantong University
Address:
City:
Xi'an
Zip:
710061
Country:
China
Status:
Recruiting
Contact:
Last name:
Guoliang Li
Phone:
008613759982523
Email:
liguoliang_med@163.com
Contact backup:
Last name:
Yang Yan
Phone:
+862985323865
Email:
yangyan3@xjtu.edu.cn
Start date:
October 26, 2023
Completion date:
July 31, 2030
Lead sponsor:
Agency:
First Affiliated Hospital Xi'an Jiaotong University
Agency class:
Other
Source:
First Affiliated Hospital Xi'an Jiaotong University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06100328
